Scientists say 40% of kidney cancer patients using a combination of drugs saw their tumours significantly reduce in size.
A new combination of smart drugs could extend the lives of thousands of cancer patients, cialis new research shows.
Results of the study reveal that the cocktail of two drugs, ipilimumab and nivolumab, “significantly reduced” the size tumours in 40% of patients with terminal kidney cancer, and 10% of those were left with “no detectable sign of cancer” at all.
The findings were revealed at the European Cancer Congress in Denmark.
Read Full Article Here >>